Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Senti Biosciences
Biotech
Senti, Celest take cell therapy to China in $156M deal
Senti’s solid tumor drug will be tested in an early-stage trial in China next year through a $156 million biobucks deal with Shanghai-based Celest.
Annalee Armstrong
Nov 7, 2023 10:15am
Senti slams brakes on CAR-NK program to eke out remaining cash
Jan 27, 2023 9:40am
Alchemab CEO resigns citing 'personal reasons'—Chutes & Ladders
May 27, 2022 9:30am
Senti shows its CAR-NK cells are more than just a gene circuit
Apr 8, 2022 1:00pm
Senti to go public in $296M SPAC deal before hitting the clinic
Dec 20, 2021 3:55pm
Precisely targeting liver cancer with logic-gated gene therapy
Dec 16, 2021 12:22pm
